IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 138 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,821,558 | -9.5% | 500,681 | -0.0% | 0.02% | -7.4% |
| Q2 2023 | $5,328,693 | +2.8% | 500,817 | +1.7% | 0.03% | -3.6% |
| Q1 2023 | $5,181,352 | +38.2% | 492,524 | +62.8% | 0.03% | +27.3% |
| Q4 2022 | $3,748,780 | +637.9% | 302,565 | +411.3% | 0.02% | +633.3% |
| Q3 2019 | $508,000 | +8.5% | 59,175 | +46.5% | 0.00% | -25.0% |
| Q4 2015 | $468,000 | +14.7% | 40,400 | +3.1% | 0.00% | +33.3% |
| Q3 2015 | $408,000 | – | 39,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |